Pfizer CEO Sold Stock On A Vaccine Announcement | $5.6 Million Deal | Pfizer Stock | PFE Analysis

Pfizer CEO sells company’s stock on the day of vaccine newsПодробнее

Pfizer CEO sold $5.6 million stock in pre-planned sale on day of vaccine news releaseПодробнее

Pfizer negotiating with U.S. to provide additional 100 million Covid-19 vaccine doses: CEOПодробнее

Pfizer CEO Albert Bourla goes one-on-one with Jim CramerПодробнее

Pfizer beats earnings estimates due to strength from Covid portfolioПодробнее

Breaking down Pfizer's CEO stock sale: Securities lawyerПодробнее

Pfizer CEO sells millions of dollars in stock after making COVID-19 vaccine announcementПодробнее

Pfizer CEO sold $5.6 million worth of stock amid the pandemicПодробнее

Pfizer CEO windfall: Drug Company boss earns 5.6 millions from share saleПодробнее

Pfizer CEO: Cancer drugs will be our next big contribution to the worldПодробнее

Pfizer forecasts $15 billion in revenue from Covid-19 vaccine in 2021Подробнее

Pfizer CEO criticizes politicization of the vaccine development processПодробнее

Covid immunity wanes 6 months after the Pfizer vaccineПодробнее

Pfizer will see Covid vaccine sales last longer than people realize: Mizuho's DivanПодробнее

Pfizer beats EPS estimates; stock falls on lower yearly guidanceПодробнее

Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by MarchПодробнее

Pfizer CEO discusses Q3 earnings, 'exceptional' growthПодробнее

Pfizer CEO Bourla on coronavirus vaccine timelineПодробнее

Wells Fargo downgrades Pfizer stock, citing need for a ‘COVID reset’Подробнее